-
公开(公告)号:US20240175086A1
公开(公告)日:2024-05-30
申请号:US18521390
申请日:2023-11-28
Applicant: Genentech, Inc.
Inventor: David F. CHOY , Tracy Lyn STATON , Brian Louis YASPAN
IPC: C12Q1/6883 , A61K31/522 , A61K45/06
CPC classification number: C12Q1/6883 , A61K31/522 , A61K45/06 , A61K2039/505
Abstract: The present invention features, inter alia, methods of treating patients having a mast cell-mediated inflammatory disease, methods of determining whether patients having a mast cell-mediated inflammatory disease are likely to respond to a therapy (e.g., a therapy comprising an agent selected from the group consisting of a tryptase antagonist, an Fc epsilon receptor (FcεR) antagonist, an IgE+ B cell depleting antibody, a mast cell or basophil depleting antibody, a protease activated receptor 2 (PAR2) antagonist, an IgE antagonist, and a combination thereof), methods of selecting a therapy for a patient having a mast cell-mediated inflammatory disease, methods for assessing a response of a patient having mast cell-mediated inflammatory disease, and methods for monitoring the response of a patient having a mast cell-mediated inflammatory disease.
-
62.
公开(公告)号:US20240173306A1
公开(公告)日:2024-05-30
申请号:US18423596
申请日:2024-01-26
Applicant: Genentech, Inc.
Inventor: Jennifer O'Hara LAUCHLE , Sandra MILAN , Melanie Carol SMITT , Marjorie C. GREEN
IPC: A61K31/437 , A61K31/519 , A61K38/09 , A61P35/00
CPC classification number: A61K31/437 , A61K31/519 , A61K38/09 , A61P35/00
Abstract: Provided herein are combination therapies comprising GDC-9545 and a CDK4/6 inhibitor for treating locally advanced breast cancer or metastatic breast cancer.
-
公开(公告)号:US11993599B2
公开(公告)日:2024-05-28
申请号:US17883004
申请日:2022-08-08
Applicant: Genentech, Inc.
Inventor: Elisia Villemure , Joachim Rudolph , Mingshuo Zeng
IPC: C07D471/14 , A61K31/501 , C07D471/08 , C07D471/10 , C07D487/14
CPC classification number: C07D471/08 , C07D471/10 , C07D487/14
Abstract: The present disclosure relates to compounds and salts thereof that are useful for modulating target polypeptides and proteins, in particular BRM. Also disclosed are pharmaceutical compositions comprising the compounds, or a salt (e.g., a pharmaceutically acceptable salt) thereof, and methods of using such compounds and salts in the treatment of various BRM-mediated and/or BRG1-mediated diseases or disorders.
-
公开(公告)号:US20240166741A1
公开(公告)日:2024-05-23
申请号:US18334531
申请日:2023-06-14
Applicant: Genentech, Inc.
Inventor: Jane Grogan , Robert J. Johnston , Bryan Irving , Jason Hackney , Xin Yu , Dan Eaton , Kristin Bowles , Laetitia Comps-Agrar
IPC: C07K16/28 , A01K67/0276 , A61K39/395 , A61K45/06 , C07K14/705 , C07K16/30
CPC classification number: C07K16/2803 , A01K67/0276 , A61K39/3955 , A61K39/39558 , A61K45/06 , C07K14/70596 , C07K16/2818 , C07K16/2827 , C07K16/3015 , C07K16/3023 , C07K16/303 , C07K16/3038 , C07K16/3046 , C07K16/3053 , C07K16/3061 , C07K16/3069 , A61K2039/507
Abstract: The present invention describes combination treatment comprising a PD-1 axis binding antagonist and an agent that decreases or inhibits TIGIT expression and/or activity and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer or chronic infection.
-
65.
公开(公告)号:US20240150491A1
公开(公告)日:2024-05-09
申请号:US18389748
申请日:2023-12-19
Applicant: Genentech, Inc.
Inventor: James Thomas KOERBER , Wyne Pun LEE , Tangsheng YI , Juan ZHANG , Cary Dean AUSTIN , Cecilia P.C. CHIU , Joseph Edward CHAVARRIA-SMITH , Jawahar SUDHAMSU
IPC: C07K16/40 , A61K39/395 , A61P17/00
CPC classification number: C07K16/40 , A61K39/3955 , A61P17/00 , A61K2039/507
Abstract: The invention provides anti-KLK7 antibodies, anti-KLK5 antibodies, anti-KLK5/KLK7 multispecific antibodies, and methods of using the same.
-
公开(公告)号:US20240136013A1
公开(公告)日:2024-04-25
申请号:US18541590
申请日:2023-12-15
Applicant: Genentech, Inc.
Inventor: Andrew J. WALLACE
IPC: G16B20/20
CPC classification number: G16B20/20
Abstract: A method for quantifying ribonucleic acid (RNA) mutation expression. For each read pair of a read pair group, a set of contiguously aligned regions and a splice junction configuration are identified. Each read pair is within a selected range of a location of interest. Each read pair of the read pair group is classified based on the set of contiguously aligned regions and the splice junction configuration that correspond to each read pair, a reference genome, and a selected mutation. A mutation-centric output is generated for the read pair group.
-
公开(公告)号:US20240124603A1
公开(公告)日:2024-04-18
申请号:US18451514
申请日:2023-08-17
Applicant: Genentech, Inc.
Inventor: Craig SMITH , Peter S. CHIN
CPC classification number: C07K16/2887 , A61B5/055 , A61K9/0019 , A61K39/00 , A61K39/3955 , A61K45/06 , G01N33/686 , G06Q99/00 , A61K2039/505 , A61K2039/507 , A61K2039/545 , A61K2039/55 , C07K2317/24 , C07K2317/565 , C07K2317/76 , G01N2800/52 , G01N2800/7095
Abstract: The present invention concerns methods for treating progressive multiple sclerosis (MS) in a patient, and an article of manufacture with instructions for such use.
-
公开(公告)号:US20240115555A1
公开(公告)日:2024-04-11
申请号:US18544236
申请日:2023-12-18
Applicant: Genentech, Inc.
Inventor: Dawn Colburn , Nicole Richie
IPC: A61K31/437 , A61K31/4523 , A61K39/395 , A61K45/06 , A61P35/04 , C07K16/28
CPC classification number: A61K31/437 , A61K31/4523 , A61K39/39558 , A61K45/06 , A61P35/04 , C07K16/2827 , A61K2039/505
Abstract: Provided herein are therapies including dosage regimens for the treatment of cancer using B-RAF and an immune checkpoint inhibitor in combination with and/or without a MEK inhibitor.
-
公开(公告)号:US20240094194A1
公开(公告)日:2024-03-21
申请号:US18518715
申请日:2023-11-24
Applicant: Genentech, Inc.
Inventor: Claudio CIFERRI , Evan Michael Green , Marc Kschonsak
IPC: G01N33/50 , G01N33/569
CPC classification number: G01N33/5091 , G01N33/56994 , C12N2503/00 , G01N2333/045 , G01N2469/10
Abstract: Provided herein are methods of treating or preventing human cytomegalovirus (HCMV) infection comprising modulating interactions between the HCMV gH/gL/UL128-131A pentamer and plasma membrane-expressed host cell proteins, as well as methods of identifying modulators of such interactions.
-
公开(公告)号:US20240092887A1
公开(公告)日:2024-03-21
申请号:US18364185
申请日:2023-08-02
Applicant: Genentech, Inc.
Inventor: Gerald R. NAKAMURA , Dhaya SESHASAYEE , Menno VAN LOOKEREN CAMPAGNE , Tiffany WONG , Jia WU , Hongkang XI , Jack BEVERS, III , Hiu Nam CHAN , Laetitia COMPS-AGRAR , Racquel CORPUZ
IPC: C07K16/24 , A61K39/395 , A61K45/06
CPC classification number: C07K16/244 , A61K39/3955 , A61K45/06 , A61K2039/505
Abstract: The invention provides interleukin-33 (IL-33) antibodies and methods of making and using the same, e.g., for treatment of IL-33 mediated disorders (e.g., ocular disorders such as AMD (e.g., geographic atrophy (GA)).
-
-
-
-
-
-
-
-
-